Perrigo Co. has received final FDA approval for its abbreviated new drug application (ANDA) for over-the-counter Famotidine chewable tablets. The drug is comparable to Pepcid Complete, produced by Johnson & Johnson and Merck Consumer Pharmaceutical and used to provide relief from heartburn associated with sour stomach and acidity. The company expects to commence shipping the product in the third quarter of 2008.

The annual retail sales for Pepcid Complete chewable tablets are estimated at about $95 million.